BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21980546)

  • 1. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.
    Stillwaggon E; Carrier CS; Sautter M; McLeod R
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1333. PubMed ID: 21980546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving.
    Prusa AR; Kasper DC; Sawers L; Walter E; Hayde M; Stillwaggon E
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005648. PubMed ID: 28692640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
    Lappalainen M; Sintonen H; Koskiniemi M; Hedman K; Hiilesmaa V; Ammälä P; Teramo K; Koskela P
    Scand J Infect Dis; 1995; 27(3):265-72. PubMed ID: 8539552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of congenital toxoplasmosis in France using prenatal screening: A decision-analytic economic model.
    Sawers L; Wallon M; Mandelbrot L; Villena I; Stillwaggon E; Kieffer F
    PLoS One; 2022; 17(11):e0273781. PubMed ID: 36331943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.
    Logar J; Petrovec M; Novak-Antolic Z; Premru-Srsen T; Cizman M; Arnez M; Kraut A
    Scand J Infect Dis; 2002; 34(3):201-4. PubMed ID: 12030394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria.
    Aspöck H; Pollak A
    Scand J Infect Dis Suppl; 1992; 84():32-7. PubMed ID: 1290071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of preventive programmes against congenital toxoplasmosis.
    Stray-Pedersen B; Jenum P
    Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening programme for congenital toxoplasmosis in France.
    Thulliez P
    Scand J Infect Dis Suppl; 1992; 84():43-5. PubMed ID: 1290073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.
    Picone O; Fuchs F; Benoist G; Binquet C; Kieffer F; Wallon M; Wehbe K; Mandelbrot L; Villena I
    J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101814. PubMed ID: 32428782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital Chagas Disease in the United States: The Effect of Commercially Priced Benznidazole on Costs and Benefits of Maternal Screening.
    Perez-Zetune V; Bialek SR; Montgomery SP; Stillwaggon E
    Am J Trop Med Hyg; 2020 May; 102(5):1086-1089. PubMed ID: 32100696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal screening for toxoplasmosis.
    Bader TJ; Macones GA; Asch DA
    Obstet Gynecol; 1997 Sep; 90(3):457-64. PubMed ID: 9277662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital toxoplasmosis: is screening desirable?
    Foulon W
    Scand J Infect Dis Suppl; 1992; 84():11-7. PubMed ID: 1290068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How can the cost of screening for toxoplasmosis during pregnancy be reduced?].
    Ancelle T; Yera H; Talabani H; Lebuisson A; Thulliez P; Dupouy-Camet J
    Rev Epidemiol Sante Publique; 2009 Dec; 57(6):411-7. PubMed ID: 19932576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological screening for toxoplasmosis in pregnancy in Slovenia.
    Logar J; Novak-Antolic Z; Zore A
    Scand J Infect Dis; 1995; 27(2):163-4. PubMed ID: 7660082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
    Paquet C; Yudin MH;
    J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?
    Eskild A; Oxman A; Magnus P; Bjørndal A; Bakketeig LS
    J Med Screen; 1996; 3(4):188-94. PubMed ID: 9041483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic serologic screening for toxoplasmosis in pregnancy.
    Thorp JM
    Obstet Gynecol; 1993 Jul; 82(1):162-3. PubMed ID: 8369057
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital Chagas Disease in the United States: Cost Savings through Maternal Screening.
    Stillwaggon E; Perez-Zetune V; Bialek SR; Montgomery SP
    Am J Trop Med Hyg; 2018 Jun; 98(6):1733-1742. PubMed ID: 29714163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the usefulness of serological examinations in the prophylaxis of congenital toxoplasmosis in the materials of CM UJ Parasitology Department].
    Dymon M; Kempińska A
    Wiad Parazytol; 2001; 47 Suppl 1():59-64. PubMed ID: 16897953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.